Ardent Health Partners’ (ARDT) “Overweight” Rating Reiterated at Stephens

Stephens restated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a report released on Thursday,Benzinga reports. Stephens currently has a $22.00 price target on the stock.

A number of other research firms also recently issued reports on ARDT. Royal Bank of Canada restated an “outperform” rating and issued a $23.00 price target on shares of Ardent Health Partners in a research report on Thursday, November 14th. Leerink Partners raised their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Morgan Stanley reduced their price target on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 21st. Finally, Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $21.36.

Ardent Health Partners Stock Down 3.3 %

Shares of ARDT stock opened at $14.66 on Thursday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a 1-year low of $13.55 and a 1-year high of $20.72. The firm has a fifty day moving average of $15.20 and a two-hundred day moving average of $16.83.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. On average, sell-side analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Institutional Investors Weigh In On Ardent Health Partners

Several institutional investors and hedge funds have recently bought and sold shares of ARDT. Ventas Inc. bought a new stake in shares of Ardent Health Partners in the 4th quarter worth about $159,570,000. Wellington Management Group LLP bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth about $28,724,000. Point72 Asset Management L.P. bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth about $27,428,000. Goldentree Asset Management LP acquired a new position in Ardent Health Partners during the 3rd quarter worth about $22,897,000. Finally, Franklin Resources Inc. acquired a new position in Ardent Health Partners during the 3rd quarter worth about $15,839,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.